This opportunity funds research to advance mechanistic understanding of neuropsychiatric symptoms in Alzheimer's disease and related dementias. It supports studies exploring biobehavioral and neurobiological pathways and aims to identify novel therapeutic targets for interventions to treat and prevent these symptoms. Clinical trials are optional within this funding mechanism.
Eligible applicants include a wide range of U.S.-based organizations such as private and public higher education institutions, state and local governments, tribal governments and organizations, nonprofits, and for-profit entities excluding small businesses. Specific eligibility details should be con
